Strain of yeast psilopsis evolutionary strain with high yield of mannosylerythritol lipid and application thereof
The phthalassin strain Pseudozymasp.M001 obtained through screening and evolution solved the problems of low production rate of mannose erythritol and high cost of glycolipid separation, achieved efficient production and emulsification performance, and laid the foundation for its industrial manufacturing. Base.
Patent Information
- Application Number
- CN202311374751.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-23
- Publication Date
- 2024-12-06
AI Technical Summary
The production rate of mannose erythritol in the prior art is low, the cost of glycolipid separation is high, and the lack of rapid transformation technology has led to its failure to industrialize on a large scale in China.
Pseudozymasp.M001, a phthalasso evolutionary strain obtained by screening and adaptive evolution through combined plasma mutagenesis, can quickly utilize various vegetable oils and improve the production efficiency and emulsification performance of mannose erythritol, overcome the slow oil utilization rate and the problem of pH drop in fermentation system.
The production of diastereomeric MEL-B with high yields was achieved, with a fermentation yield of 66g/L, which improved the emulsification performance and skin feel of mannose erythritol, and laid the foundation for its industrialized biomanufacturing.
Smart Images

Figure CN119081896A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bioengineering, and specifically relates to an evolved pseudo-saccharomyces strain with high mannose erythritol lipid production and application thereof. Background Art
[0002] In recent years, the development of economical and sustainable bioprocesses has gradually replaced the production methods of existing products based on petrochemicals. The market demand for surfactants has achieved rapid growth year by year. Among them, biosurfactants are amphiphilic metabolites produced by microbial fermentation with both hydrophilic and hydrophobic parts. Compared with traditional petroleum-based chemical surfactants, biosurfactants produced by microorganisms using sugars, oils, and carbohydrates as raw materials in a clean process have the advantages of low toxicity, wide applicability, biodegradability, high stability under extreme temperatures, pH and salinity, and unique biological activity. Therefore, they can replace chemical surfactants and be used in food, daily chemicals, medicine, environmental protection, agriculture and other fields.
[0003] Mannosylerythritol lipids (MELs) are nonionic glycolipid biosurfactants. Mannosylerythritol lipids have been reported to have four different structural types, which can be divided into four homologues, MEL-A, MEL-B, MEL-C and MEL-D, according to the degree of acetylation on the sugar group. Mannosylerythritol lipids not only have good properties of biological surface activity, such as good emulsification, biodegradability, low critical micelle concentration, etc., but also have many special physiological activities, such as antibacterial activity, inducing cell mutation, differentiating human myeloid leukemia cell lines and melanoma cells, improving gene transfection efficiency and having strong coordination ability with glycoproteins, etc. Patent document CN113817617A provides a strain of aphid pseudoyeast, which is used to ferment and produce MEL-ABC mixed crude sugar lipids with a yield of 96g / L. However, compared with the MEL-ABC mixed type, the diastereomer MEL-B spontaneously assembles into a lamellar phase within a wide concentration and temperature range, and forms relatively large vesicles at low concentrations. Therefore, diastereomer MEL-B has good application prospects in drugs, gene delivery and transdermal drug delivery systems. At the same time, due to the unique configuration of erythrose, diastereomer MEL-B exhibits superior skin care performance than conventional MEL-B. The microorganisms reported so far for synthesizing mannitol erythritol lipids are mainly molds and pseudo yeasts. Due to the lack of rapid transformation technology for such production strains, coupled with the high cost of glycolipid separation and low production rate and other reasons, mannitol erythritol lipids have not yet been industrialized on a large scale in China. Patent CN109196091B discloses a recombinant microorganism having an exogenous nucleic acid encoding a lipase and having the ability to produce mannitol erythritol lipids. The expression of exogenous lipase is enhanced by non-homologous recombination, which can increase the oil consumption rate and MEL production rate. However, expensive antibiotics need to be added during the fermentation of the strain to maintain stability. Summary of the invention
[0004] The purpose of this section is to summarize some aspects of embodiments of the present invention and briefly introduce some preferred embodiments. Some simplifications or omissions may be made in this section and the specification abstract and the invention title of this application to avoid blurring the purpose of this section, the specification abstract and the invention title, and such simplifications or omissions cannot be used to limit the scope of the present invention.
[0005] In view of the above problems and / or the problems existing in the prior art, the present invention is proposed.
[0006] Therefore, the purpose of the present invention is to overcome the shortcomings of the prior art and provide a pseudo yeast evolution strain with high production of mannose erythritol lipids, characterized in that: the pseudo yeast evolution strain is named Pseudozymasp.M001, deposited in the China Center for Type Culture Collection, with a deposit number of CCTCC NO: M2023766, and a deposit date of May 17, 2023.
[0007] Another object of the present invention is to overcome the deficiencies in the prior art and provide an application of a pseudo-Saccharomyces cerevisiae evolved strain in the industrial production of mannose erythritol lipids.
[0008] As a preferred embodiment of the application of the present invention, the method of using the pseudo-Saccharomyces cerevisiae evolved strain in the industrial production of mannose erythritol lipids comprises:
[0009] The strain was inoculated into a medium composed of 30 g / L glucose, NaNO 3 1 g / L, soy peptone 3g / L, KH 2 PO 4 3g / L, MgSO 4 0.3 g / L seed medium, cultured for 48 h;
[0010] 5-10% was inoculated into a mixture composed of 20 g / L glucose, 100 g / L olive oil, and NaNO 3 3 g / L, soy peptone 1g / L, KH 2 PO 4 0.3 g / L, MgSO 4 Fermentation was carried out in 0.3 g / L fermentation medium for 168 h.
[0011] As a preferred embodiment of the application of the present invention, the mannose erythritol lipid produced by the Saccharomyces pseudosaccharomyces evolved strain is the diastereomer MEL-B.
[0012] As a preferred embodiment of the application of the present invention, the fermentation yield of diastereomer MEL-B produced by the Saccharomyces pseudosaccharomyces evolved strain can reach 66 g / L.
[0013] Beneficial effects of the present invention:
[0014] The present invention screens and obtains a pseudo yeast with better production performance of type B mannitol erythritol lipid, and the mutant strain obtained by combined plasma mutagenesis adaptive evolution has fast oil utilization speed and high glycolipid production efficiency, which overcomes the shortcomings of the existing type B mannitol erythritol lipid strain, such as slow oil utilization and fatty acid consumption speed, and the decrease in pH of the fermentation system. The prepared type B mannitol erythritol lipid has better emulsification performance and skin feel than ABC mixed glycolipid. In addition, the evolved strain can quickly utilize various types of plant oils and fats, and produce high-yield mannose erythritol lipid, laying a foundation for the subsequent industrialized biomanufacturing of type B mannitol erythritol lipid. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following briefly introduces the drawings required for describing the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative labor. Among them:
[0016] Figure 1 This is a comparison diagram of the effect of the mannose erythritol lipid of the present invention on surface tension;
[0017] Figure 2 The colony morphology of the pseudo-yeast of the present invention;
[0018] Figure 3 is a molecular evolutionary tree of the pseudo-Saccharomyces cerevisiae of the present invention;
[0019] Figure 4 This is a TLC analysis chart of the synthetic mannose erythritol lipid by the pseudo yeast of the present invention;
[0020] Figure 5 A comparison chart of the glycolipid yields of mannose erythritol lipids synthesized by the evolved strains of the present invention;
[0021] Figure 6 This is a comparison chart of the glycolipid yields of the strain of the present invention using various plant oils to synthesize mannose erythritol lipids;
[0022] Figure 7 This is a yield diagram of the fermentation process of mannose erythritol lipid synthesis by the strain of the present invention in batch feeding.
[0023] Figure 8 This is a graph showing the emulsification performance test results of the strain of the present invention synthesizing mannose erythritol lipid.
[0024] Fig. 9 This is a graph showing the skin feel test results of the strain of the present invention synthesizing mannose erythritol lipid.
[0025] Fig.10This is a comparison chart of the refreshing feeling and the later oily feeling of the B-type mannose erythritol lipid synthesized by the strain of the present invention and the mixed glycolipid. DETAILED DESCRIPTION
[0026] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific implementation methods of the present invention are described in detail below in conjunction with the embodiments of the specification.
[0027] In the following description, many specific details are set forth to facilitate a full understanding of the present invention, but the present invention may also be implemented in other ways different from those described herein, and those skilled in the art may make similar generalizations without violating the connotation of the present invention. Therefore, the present invention is not limited to the specific embodiments disclosed below.
[0028] Secondly, the term "one embodiment" or "embodiment" as used herein refers to a specific feature, structure, or characteristic that may be included in at least one implementation of the present invention. The term "in one embodiment" that appears in different places in this specification does not necessarily refer to the same embodiment, nor does it refer to a separate or selective embodiment that is mutually exclusive with other embodiments.
[0029] In an embodiment of the present invention, a pseudo yeast evolution strain for high production of mannose erythritol lipids using vegetable oil is provided. The strain is named Pseudozyma sp.M001, which has been deposited in the China Center for Type Culture Collection (CCTCC, address: Wuhan University, Wuhan, China) on May 17, 2023, and its deposit number is CCTCC NO: M 2023766.
[0030] Unless otherwise specified, the raw materials used in the examples of the present invention are all commercially available.
[0031] The assay method used in the embodiments of the present invention is:
[0032] Anthrone sulfuric acid method: After the fermentation broth is extracted and diluted with ethyl acetate in equal proportions, 200 μL of the dilution and 800 μL of anthrone reagent (0.2% (w / v) anthrone sulfuric acid solution) are evenly mixed, reacted in a boiling water bath for 10 minutes, and the absorbance at 625 nm is measured. A standard curve is drawn with mannoerythritol lipids with a concentration gradient of 0 to 1 g / L as the standard solution to determine the sugar ester concentration in the fermentation broth.
[0033] TLC analysis: After the fermentation broth was extracted with an equal proportion of ethyl acetate, 1 uL was aspirated and separated on a silica gel plate using a developing solvent of chloroform:methanol:ammonia water=65:15:2 and color was developed using potassium permanganate.
[0034] HPLC analysis: The chromatographic column used was a Shimadzu silica gel column (Inertsil SIL 100A 5 μm), the mobile phase was chloroform (liquid A) and methanol (liquid B), the elution conditions were: 0 min, 0% B; 0-30 min, 0% B increased to 100% B, and then maintained for 10 min, the flow rate was 1.0 mL / min, the column oven was 30° C., and the evaporative light detector temperature was 42° C. A standard curve was drawn using 0-1 g / L mannoerythritol lipid as the standard solution to determine the sugar ester concentration in the fermentation broth.
[0035] Example 1
[0036] The screening of the original strain includes the following steps:
[0037] Collect 1 g of the mixed sample of Cinnamomum camphora leaves and Perilla frutescens leaves, add 99 mL of sterile water, and culture on a shaker at 25 °C for 30 min; draw 1 mL of the liquid and inoculate it in MELS medium (soybean oil 20 g / L, NaNO 3 1 g / L, soy peptone 5g / L, KH 2 PO 4 0.3 g / L, MgSO 4 0.3 g / L) for 48 h;
[0038] 100uL of bacterial solution was spread on a YM (10g / L glucose, 5g / L tryptone, 3g / L malt extract powder and 3g / L yeast extract powder) solid plate and cultured for 48h;
[0039] 150 single colonies were inoculated into MELS medium (soybean oil 40 g / L, NaNO 3 1 g / L, soy peptone 5g / L, KH 2 PO 4 0.3 g / L, MgSO 4 0.3 g / L) for 168 h;
[0040] 30uL of fermentation liquid was taken and placed on Parafilm M paraffin film, and 10 strains capable of producing mannose erythritol lipid were screened out by measuring the diameter of the droplets. The fermentation liquid of these 10 strains was extracted with ethyl acetate, and the content of mannose erythritol lipid was determined by the anthrone sulfate method, thereby obtaining the strain with the strongest production ability, which was recorded as MEL55.
[0041] The fermentation broth of strain MEL55 was dispersed on Parafilm M as Figure 1 As shown, the left side is blank culture medium, and the right side is fermentation broth of MEL55 (50uL each).
[0042] Example 2
[0043] The identification of the original strain includes the following steps:
[0044] 1. Colony morphology
[0045] The original strain MEL55 was cultured on YM (10 g / L glucose, 5 g / L tryptone, 3 g / L malt extract powder and 3 g / L yeast extract powder) solid medium at 28°C for 48 h. The colony morphology was as follows: Figure 2 As shown, the colonies are light yellow with smooth surface and neat edges.
[0046] 2. Phylogenetic tree construction
[0047] The genome of MEL55 was used as a template and universal primers 26S-F (5'-GCATATCAATAA GCGGAGGAA-3') and 26S-R (5'-GGTCCGTGTTTCAAGAC-3') were used to amplify the 26S rDNA sequence fragment. The amplified nucleic acid fragment was sequenced by Suzhou GeneWeizhi Company.
[0048] The obtained sequences were compared with the NCBI database using BLAST, compared with neighboring species, and analyzed by multiple comparisons using CLUSTALX. The phylogenetic tree was constructed using MEGA 5.0. The results are shown in the figure. Figure 3 As shown, MEL55 showed 99% identity with Candidasp.SY16 and Pseudozymatsukubaensis.
[0049] Example 3
[0050] The qualitative analysis of mannose and erythritol lipids includes the following steps:
[0051] The strain MEL55 was grown in MELS medium (NaNO 3 1 g / L, soy peptone 5g / L, KH 2 PO 4 0.3 g / L, MgSO 4 The culture was carried out in 0.3 g / L (pH 7.0) for 168 h, and the fermentation broth was extracted with ethyl acetate and analyzed by TLC.
[0052] TLC analysis results are as follows Figure 4 As shown, each oil as a carbon source has only one glycolipid band with a mobility of 0.5, which is consistent with the standard MEL-B.
[0053] Example 4
[0054] Combinatorial mutagenesis adaptive evolution screening includes the following steps:
[0055] Take 20uL 1*10 8 The suspension of CFU / mL logarithmic phase bacteria was placed in a plasma mutagenizer (Wuxi Yuanqing Tianmu Biotechnology Co., Ltd., plasma mutagenizer breeding instrument ARTP-M, lethality 90%) for 50 seconds, and then spread on a YM (10g / L glucose, 5g / L tryptone, 3g / L malt extract powder and 3g / L yeast extract powder) solid plate and cultured for 48 hours. 80 colonies with larger colony diameter and regular morphology were selected and recorded as MEL55-1, MEL55-2, ..., MEL55-80;
[0056] The 80 mutant strains were verified by shake flask fermentation. 5% was inoculated into MELS medium (soybean oil 80g / L, NaNO 3 1 g / L, soy peptone 5g / L, KH 2 PO 4 0.3 g / L, MgSO 4 0.3 g / L) for 168 h;
[0057] The fermentation broth was extracted with ethyl acetate and then analyzed by HPLC to calculate the mannosyl erythritol lipid production of each mutant strain. Figure 5 As shown, it can be seen that the yields of 5 strains are higher than that of MEL55, among which MEL55-28 has the highest yield of 28 g / L.
[0058] MEL55-28 was inoculated into adaptive evolution medium-1 (soybean oil 20 g / L, NaNO 3 3g / L, soy peptone 5g / L, KH 2 PO 4 1 g / L, MgSO 4 0.3 g / L) for 48 h (three parallel groups were carried out simultaneously, recorded as: AMEL1-1, AMEL2-1, AMEL3-1), and then 5% was inoculated into the above adaptive evolution medium and continued to be cultured for 48 h to obtain AMEL1-2, AMEL2-2, and AMEL3-2. After 30 consecutive transfers, 5% was inoculated into adaptive evolution medium-2 (soybean oil 30 g / L, NaNO 3 3g / L, soy peptone 3g / L, KH 2 PO 4 1 g / L, MgSO 4 0.3 g / L) and transferred 50 times in the same way, and then inoculated into adaptive evolution medium-3 (soybean oil 40 g / L, NaNO 3 3g / L, soy peptone 1g / L, KH 2 PO 4 1 g / L, MgSO4 0.3 g / L), and after 70 consecutive transfers using the same method, AMEL1-150, AMEL2-150, and AMEL3-150 were obtained.
[0059] AMEL1-150, AMEL2-150, and AMEL3-150f were spread on YM (10 g / L glucose, 5 g / L tryptone, 3 g / L malt extract powder, and 3 g / L yeast extract powder) solid plates and cultured for 48 h. Thirty colonies with larger colony diameters and regular morphology were selected. The 30 evolved strains were verified by shake flask fermentation and inoculated into MELS medium (80 g / L soybean oil, NaNO 3 3 g / L, soy peptone 1g / L, KH 2 PO 4 1 g / L, MgSO 4 0.3 g / L) for 120 h, and the yield of glycolipid fermentation was analyzed.
[0060] Among them, the fermentation yield of the evolved strain AMEL2-150-8 was the highest at 35 g / L. The strain was named Pseudozymasp.M001 and deposited in the China Center for Type Culture Collection with the deposit number CCTCCNO: M 2023766. The evolved strain can ferment a variety of vegetable oils to produce mannose erythritol lipids, such as Figure 6 shown.
[0061] Example 5
[0062] Fed-batch fermentation includes the following steps:
[0063] (1) Seed culture: The Pseudozyma sp.M001 strain was inoculated into 50 mL of seed culture medium and cultured for 24 h to obtain primary seeds; 100 mL of primary seeds were inoculated into a seed tank containing 2 L of seed culture medium and cultured for 24 h to obtain secondary seeds.
[0064] (2) Fermentation: 2 L of seed culture medium was inoculated into 30 L of fermentation medium (20 g / L glucose, 100 g / L soybean oil, NaNO 3 3 g / L, soy peptone 1g / L, KH 2 PO 4 0.3 g / L, MgSO 4 0.3g / L) for 200h, the fermentation conditions were controlled at 300rpm, 28℃, 0.2-1vvm, and 100g / L olive oil was added at 100h. Figure 7 As shown, the fermentation yield of MEL-B reached 66 g / L after 9 days.
[0065] Example 6
[0066] The application of mannose erythritol lipid MEL-B comprises the following steps:
[0067] (1) Emulsification: 10% of oil was emulsified with 0.1% of MEL-ABC mixed type (Belgian Orian ML-10) and MEL-B prepared in Example 5, and the particle size distribution was compared under a microscope.
[0068] The particle size comparison results are as follows Figure 8 As shown (A is MEL-ABC, B is MEL-B). Obviously, compared with MEL-ABC (5-30μm), the particle size distribution of MEL-B is finer and denser (5-10μm), and the stability is more superior, which shows that MEL-B can achieve the effect of timely emulsification at a low addition amount, and the emulsification ability of water-in-oil dosage form is better than that of MEL-ABC mixed sugar ester.
[0069] (2) Skin feel: 2% MEL-ABC mixed type (Belgian Olian ML-10) and MEL-B prepared in Example 5 were added to the oil to compare the difference in skin feel. Multiple people were selected to conduct skin feel evaluation tests. The test results are shown in Tables 1 and Fig. 9 , Fig.10 shown.
[0070] Table 1 Skin feel evaluation test results
[0071]
[0072] It can be seen that the skin feel advantage of MEL-B is that it is more refreshing to touch, gradually moisturizing during the absorption process but not sticky, the absorption speed is relatively fast, and the skin is soft and elastic after absorption.
[0073] Comparative Example 1
[0074] The difference between this comparative example and Example 5 is that the fermentation medium contains 20 g / L glycerol, 100 g / L olive oil, NaNO 3 3 g / L, soy peptone 5g / L, KH 2 PO 4 0.3 g / L, MgSO 4 0.3 g / L, the rest of the process is the same as Example 5, after 75h of fermentation, it was found that the oil consumption stopped, and after 9d of fermentation, the MEL-B fermentation yield was only 15g / L. Therefore, under the condition of excessive nitrogen source, the consumption of oil and the synthesis of mannose erythritol lipids are inhibited.
[0075] Comparative Example 2
[0076] Batch fed fermentation, the difference between this example and Example 5 is that the inoculated strain is the conventionally used diastereomeric MEL-B fermentation strain Pseudozymatsukubaensis ATCC 24555, and the rest of the process is the same as that of Example 5. After 9 days, the MEL-B fermentation yield is only 45 g / L, and the residual oil, monoglyceride, diglyceride fatty acid and glycolipid form very viscous solids that adhere to the agitator and the tank body, making it difficult to put the product into the tank.
[0077] The pseudo-yeast evolution strain obtained by adaptive evolution in the present invention has a fast oil utilization speed and high glycolipid production efficiency, and overcomes the shortcomings of the existing B-type mannose erythritol lipid strain, such as slow oil utilization and fatty acid consumption, and a decrease in the pH of the fermentation system. The strain can quickly utilize various types of plant oils and fats and produce high mannose erythritol lipids, laying a foundation for the subsequent industrialized biomanufacturing of B-type mannose erythritol lipids.
[0078] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solutions of the present invention can be modified or replaced by equivalents without departing from the spirit and scope of the technical solutions of the present invention, which should all be included in the scope of the present invention.
Claims
1. An evolved pseudo-Saccharomyces strain with high mannose-erythritol lipid production, characterized by: The pseudoyeast evolution strain was named Pseudozymasp.M001, deposited in the China Center for Type Culture Collection, with the deposit number CCTCC NO: M2023766, and the deposit date was May 17, 2023.
2. Use of the pseudo-Saccharomyces cerevisiae evolved strain as claimed in claim 1 in the industrial production of mannose erythritol lipids.
3. The use according to claim 2, characterized in that: The method of using the pseudo-Saccharomyces cerevisiae evolved strain in the industrial production of mannose erythritol lipids comprises: The strain was inoculated into a seed medium composed of 30 g / L glucose, 31 g / L NaNO, 3 g / L soy peptone, 3 g / L KH2PO4, and 0.3 g / L MgSO4 and cultured for 48 h; The culture medium was inoculated at 5-10% and fermented for 168 hours with the composition of 20 g / L glucose, 100 g / L olive oil, 3 g / L NaNO3, 1 g / L soy peptone, 0.3 g / L KH2PO4 and 0.3 g / L MgSO4.
4. The use according to claim 2, characterized in that: The mannose erythritol lipid produced by the pseudo-yeast evolution strain is the diastereomer MEL-B.
5. The use according to claim 4, characterized in that: The fermentation yield of the diastereomer MEL-B produced by the pseudo-Saccharomyces cerevisiae evolved strain can reach 66 g / L.
